Sodium glucose co‐transporter‐2 inhibitor‐induced diabetic ketoacidosis following tooth extraction: improving awareness among dental practitioners

Sodium glucose co‐transporter‐2 inhibitors (SGLT‐2i) are a relatively new class of oral glucose lowering agents that improve glycaemic control and also provide significant cardiac and renal benefits. However, SGLT‐2i use is associated with a small but significant increased risk of diabetic ketoacido...

Ausführliche Beschreibung